Skip to main content

Gilead Sciences Invests in Research for COVID-19 Treatments for All Ages

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

Children are being hospitalized with COVID 19 at increasingly high rates, and those younger than 5 aren't eligible to receive a vaccine. We’re committed to helping in this area by investing in research for COVID-19 treatments for all ages.

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences.

Tweet me: .@GileadSciences is committed to helping children being hospitalized with #COVID19 by investing in research for COVID-19 treatments for all ages. #CROI2022 https://bit.ly/3GNxutP

KEYWORDS: NASDAQ: GILD, COVID-19, CROI2022

Chart showing increase in COVID-19 hospitalizations among children in the US

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.26
+5.40 (2.64%)
AAPL  262.90
+2.32 (0.89%)
AMD  204.18
+0.81 (0.40%)
BAC  52.53
-0.24 (-0.45%)
GOOG  315.13
+11.57 (3.81%)
META  657.50
+12.72 (1.97%)
MSFT  399.21
+0.75 (0.19%)
NVDA  189.88
+1.98 (1.05%)
ORCL  152.57
-3.97 (-2.53%)
TSLA  412.83
+1.12 (0.27%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.